Evidence map›Paper›PMID 42377386›Full record

ArticleMolecular biology reports2026

Overexpression of the BRC repeat 8 of BRCA2 hyperstabilizes RAD51 and alters DNA repair dynamics.

Zida Zhu, Taisuke Kitano, Masami Morimatsu, Koichi Orino, Yasunaga Yoshikawa

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zida ZhuLaboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Higashi23-35-1, Towada, 034-8628, Aomori, Japan.
Taisuke KitanoLaboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Higashi23-35-1, Towada, 034-8628, Aomori, Japan.
Masami MorimatsuLaboratory of Laboratory Animal Science and Medicine, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, 060- 0818, Japan.
Koichi OrinoLaboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Higashi23-35-1, Towada, 034-8628, Aomori, Japan.
Yasunaga YoshikawaLaboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Higashi23-35-1, Towada, 034-8628, Aomori, Japan. yyoshika@vmas.kitasato-u.ac.jp.ORCID https://orcid.org/0000-0003-4257-3088

Funding

Japan Society for the Promotion of Science 23K05575Japan Society for the Promotion of Science 24KJ1924
6 · The paper itself

Abstract

backgroundRAD51 plays an essential role in maintaining genomic stability via homologous recombination (HR). Aberrant RAD51 expression compromises genomic integrity and influences cellular responses to DNA-damaging agents. RAD51 expression is tightly regulated in normal cells, and its increased expression is associated with therapeutic resistance and poor prognosis in various cancers. BRCA2, a tumor suppressor gene product, promotes HR by directly interacting with RAD51 via eight evolutionarily conserved BRC repeats (BRC1-8). Individual BRC repeats share relatively low sequence similarity and possess distinct biochemical properties. We previously reported that the expression of certain BRC repeat peptides alters RAD51 protein levels, suggesting that individual BRC repeats distinctly affect RAD51 expression. METHODS AND

resultsWe aimed to identify the specific BRC repeat regions affecting RAD51 protein levels. Notably, BRC8 expression significantly elevated RAD51 protein levels and foci formation, possibly by inhibiting its ubiquitin-mediated degradation. Paradoxically, despite increased RAD51 foci formation, BRC8 expression significantly reduced HR repair efficiency and increased sensitivity to DNA-damaging agents.

conclusionsOur findings suggest that BRC8 overexpression stabilizes RAD51 by inhibiting ubiquitin-dependent degradation of RAD51, leading to increased persistence of RAD51 foci, indicating impaired timely removal of RAD51 from DNA damage sites and reduced HR efficiency. Moreover, altered cell cycle distribution may contribute to reduced non-homologous end-joining efficiency, further enhancing cellular sensitivity to DNA-damaging agents. Collectively, these findings provide a basis to further explore the potential of BRC8-based peptides as tools for modulating RAD51 stability and sensitizing cells to DNA damage.

Indexed as

BRCA2 ProteinDNA RepairRad51 RecombinaseCell Line, TumorDNA DamageGenomic InstabilityHomologous RecombinationHumansBRCA2 ProteinBRCA2 protein, humanRAD51 protein, humanRad51 RecombinaseBRCA2DNA damageGenome stabilityHomologous recombinationRAD51Ubiquitination

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.